| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Roel Smolders | Q47643090 |
| Ruth Bevan | Q114423470 | ||
| Holger Martin Koch | Q40143764 | ||
| Kate Jones | Q41718769 | ||
| Lesa L. Aylward | Q43270055 | ||
| P2093 | author name string | Nicholas Warren | |
| John Cocker | |||
| Len Levy | |||
| Sean M Hays | |||
| P2860 | cites work | Assessment of variability in biomonitoring data using a large database of biological measures of exposure | Q23912463 |
| Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: a review | Q23917734 | ||
| Applicability of non-invasively collected matrices for human biomonitoring | Q24653435 | ||
| Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements | Q24814239 | ||
| Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents | Q44577294 | ||
| Age-related trends in urinary excretion of bisphenol A in Australian children and adults: evidence from a pooled sample study using samples of convenience. | Q44643246 | ||
| Determination of free and total bisphenol A in human urine to assess daily uptake as a basis for a valid risk assessment | Q46519427 | ||
| Decreases in urine specific gravity and urinary creatinine in elderly women | Q46549632 | ||
| Quantitation of bisphenol A and bisphenol A glucuronide in biological samples by high performance liquid chromatography-tandem mass spectrometry. | Q46652706 | ||
| Effect of creatinine and specific gravity normalization techniques on xenobiotic biomarkers in smokers' spot and 24-h urines | Q46719297 | ||
| Framework for the development and application of environmental biological monitoring guidance values | Q47642969 | ||
| Identifying sources of phthalate exposure with human biomonitoring: results of a 48h fasting study with urine collection and personal activity patterns. | Q51279501 | ||
| Conclusions and recommendations of the expert panel: technical workshop on human milk surveillance and biomonitoring for environmental chemicals in the United States. | Q52936603 | ||
| Temporal Variability in Urinary Phthalate Metabolite Excretion Based on Spot, Morning, and 24-h Urine Samples: Considerations for Epidemiological Studies | Q57796126 | ||
| Biomarker variance component estimation for exposure surrogate selection and toxicokinetic inference | Q28385078 | ||
| Variability of urinary concentrations of bisphenol A in spot samples, first morning voids, and 24-hour collections | Q28394096 | ||
| Interpreting variability in population biomonitoring data: Role of elimination kinetics | Q28950877 | ||
| Chlorinated hydrocarbon levels in human serum: effects of fasting and feeding | Q29547389 | ||
| Trends in blood lead levels in UK workers, 1995–2007 | Q30451681 | ||
| Human milk biomonitoring data: interpretation and risk assessment issues | Q31006357 | ||
| Modeling interchild differences in pharmacokinetics on the basis of subject-specific data on physiology and hepatic CYP2E1 levels: a case study with toluene. | Q31031970 | ||
| Estimating absorbed dose of pesticides in a field setting using biomonitoring data and pharmacokinetic models. | Q31145312 | ||
| Extrapolation of in vitro enzyme induction data to humans in vivo | Q32174139 | ||
| An approach for the quantitative consideration of genetic polymorphism data in chemical risk assessment: examples with warfarin and parathion. | Q33184905 | ||
| Bisphenol A in 24 h urine and plasma samples of the German Environmental Specimen Bank from 1995 to 2009: a retrospective exposure evaluation | Q33454779 | ||
| Estimating perchlorate exposure from food and tap water based on US biomonitoring and occurrence data | Q33613554 | ||
| Intrinsic human elimination half-lives of polychlorinated biphenyls derived from the temporal evolution of cross-sectional biomonitoring data from the United Kingdom | Q33713949 | ||
| Human biomonitoring assessment values: approaches and data requirements. | Q33963192 | ||
| Variability over 1 week in the urinary concentrations of metabolites of diethyl phthalate and di(2-ethylhexyl) phthalate among eight adults: an observational study | Q34407507 | ||
| Urine as a biological specimen for forensic analysis of alcohol and variability in the urine-to-blood relationship | Q34549600 | ||
| Dioxin risks in perspective: past, present, and future. | Q35119488 | ||
| Variability of urinary concentrations of polycyclic aromatic hydrocarbon metabolite in general population and comparison of spot, first-morning, and 24-h void sampling | Q36191471 | ||
| Hydration biomarkers in free-living adults with different levels of habitual fluid consumption. | Q36800973 | ||
| Human variability in hepatic and renal elimination: implications for risk assessment | Q36819716 | ||
| Creatinine corrections for estimating children's and adult's pesticide intake doses in equilibrium with urinary pesticide and creatinine concentrations. | Q36945544 | ||
| A multi-individual pharmacokinetic model framework for interpreting time trends of persistent chemicals in human populations: application to a postban situation. | Q37291881 | ||
| Non-invasive matrices in human biomonitoring: a review. | Q37308348 | ||
| A review on the practical application of human biomonitoring in integrated environmental health impact assessment | Q37398936 | ||
| Influence of systems biology response and environmental exposure level on between-subject variability in breath and blood biomarkers | Q37594115 | ||
| Reconstructing human exposures using biomarkers and other "clues". | Q37971821 | ||
| Variability of urinary excretion of pyrethroid metabolites in seven persons over seven consecutive days--implications for observational studies. | Q40113640 | ||
| Physiological-model-based derivation of the adult and child pharmacokinetic intraspecies uncertainty factors for volatile organic compounds | Q40718371 | ||
| Rapid urinary output normalization method using specific gravity | Q41981615 | ||
| Variability of biomarkers in volunteer studies: The biological component | Q42666522 | ||
| Ancient gut microbiomes shed light on modern disease | Q43201392 | ||
| P433 | issue | 1 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 45-61 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | Journal of Toxicology and Environmental Health Part B: Critical Reviews | Q15724534 |
| P1476 | title | Sources of variability in biomarker concentrations | |
| P478 | volume | 17 |
| Q92811618 | A comparative assessment of dilution correction methods for spot urinary analyte concentrations in a UK population exposed to arsenic in drinking water |
| Q38286283 | A curated review of recent literature of biomarkers used for assessing air pollution exposures and effects in humans |
| Q95328921 | Accounting for urinary dilution in peri-implantation samples: implications for creatinine adjustment and specimen pooling |
| Q38599895 | Arsenic and Obesity: A Comparison of Urine Dilution Adjustment Methods |
| Q36048730 | Assessing urinary flow rate, creatinine, osmolality and other hydration adjustment methods for urinary biomonitoring using NHANES arsenic, iodine, lead and cadmium data |
| Q38978376 | Associations between urinary diphenyl phosphate and thyroid function. |
| Q48513647 | Biomonitoring Equivalents for interpretation of urinary iodine |
| Q39923860 | Biomonitoring Equivalents for molybdenum. |
| Q36271455 | CO-occurring exposure to perchlorate, nitrate and thiocyanate alters thyroid function in healthy pregnant women |
| Q38619277 | Cadmium or cadmium compounds and chronic kidney disease in workers and the general population: a systematic review |
| Q38367324 | Challenges for environmental epidemiology research: are biomarker concentrations altered by kidney function or urine concentration adjustment? |
| Q97640787 | Cluster analysis of urinary tobacco biomarkers among U.S. adults: Population Assessment of Tobacco and Health (PATH) biomarker study (2013-2014) |
| Q60955301 | Comparison of Nicotine and Toxicant Exposure in Users of Electronic Cigarettes and Combustible Cigarettes |
| Q40728711 | Contemporary Issues in Exposure Assessment Using Biomonitoring |
| Q47182969 | Critical and systematic evaluation of data for estimating human exposures to 2,4-dichlorophenoxyacetic acid (2,4-D) - quality and generalizability |
| Q31134245 | Derivation of biomonitoring equivalent for inorganic tin for interpreting population-level urinary biomonitoring data |
| Q91824203 | Derivation of biomonitoring equivalents (BE values) for zinc |
| Q63246774 | Dried Blood Spots for Global Health Diagnostics and Surveillance: Opportunities and Challenges |
| Q41051311 | Hair analysis for the biomonitoring of pesticide exposure: comparison with blood and urine in a rat model |
| Q38968107 | Including non-dietary sources into an exposure assessment of the European Food Safety Authority: The challenge of multi-sector chemicals such as Bisphenol A. |
| Q59836262 | Intra-household agreement of urinary elemental concentrations in Tanzania and Kenya: potential surrogates in case–control studies |
| Q53217645 | Kinetics of Diol and Hydroxybenzo[a]pyrene Metabolites in Relation to DNA Adduct Formation and Gene Expression in Rats. |
| Q28392644 | Measurement and Comparison of Organic Compound Concentrations in Plasma, Whole Blood, and Dried Blood Spot Samples |
| Q64131869 | Nitromethane Exposure from Tobacco Smoke and Diet in the U.S. Population: NHANES, 2007-2012 |
| Q90224266 | Normalizing Untargeted Periconceptional Urinary Metabolomics Data: A Comparison of Approaches |
| Q28383963 | Oxidatively damaged guanosine in white blood cells and in urine of welders: associations with exposure to welding fumes and body iron stores |
| Q53405822 | Plasma metabolomic biomarkers accurately classify acute mild traumatic brain injury from controls. |
| Q51105138 | Potential application of benzo(a)pyrene-associated adducts (globin or lipid) as blood biomarkers for target organ exposure and human risk assessment. |
| Q40107989 | Preparation and performance features of wristband samplers and considerations for chemical exposure assessment |
| Q92132120 | Reproducibility of essential elements chromium, manganese, iron, zinc and selenium in spot samples, first-morning voids and 24-h collections from healthy adult men |
| Q51306338 | Requirement for specific gravity and creatinine adjustments for urinary steroids and luteinizing hormone concentrations in adolescents. |
| Q88621000 | Risk assessment and Biomonitoring Equivalent for 2-ethylhexyl-2,3,4,5 tetrabromobenzoate (TBB) and tetrabromobenzoic acid (TBBA) |
| Q52614286 | Silicone wristbands compared with traditional polycyclic aromatic hydrocarbon exposure assessment methods. |
| Q42872895 | Studies Need More than a Spot Sample: Variability of Urinary Metal Levels over Time |
| Q38675795 | The One Health Perspective in Trace Elements Biomonitoring. |
| Q90398342 | The Relationship Between Widespread Pollution Exposure and Oxidized Products of Nucleic Acids in Seminal Plasma and Urine in Males Attending a Fertility Center |
| Q61853428 | Toward Capturing the Exposome: Exposure Biomarker Variability and Coexposure Patterns in the Shared Environment |
| Q28393967 | Urinary arsenic profiles reveal exposures to inorganic arsenic from private drinking water supplies in Cornwall, UK |
| Q28082837 | Uses of NHANES Biomarker Data for Chemical Risk Assessment: Trends, Challenges, and Opportunities |
| Q52739774 | Variability and exposure classification of urinary levels of non-essential metals aluminum, antimony, barium, thallium, tungsten and uranium in healthy adult men. |
| Q36793444 | Variability of Metal Levels in Spot, First Morning, and 24-Hour Urine Samples over a 3-Month Period in Healthy Adult Chinese Men. |
| Q35256500 | Variation in urinary flow rates according to demographic characteristics and body mass index in NHANES: potential confounding of associations between health outcomes and urinary biomarker concentrations |
| Q39322972 | Variation in urinary spot sample, 24 h samples, and longer-term average urinary concentrations of short-lived environmental chemicals: implications for exposure assessment and reverse dosimetry |
Search more.